Conference call scheduled for May 12, 2008 at 1:30 p.m. (Pacific);
simultaneous webcast at http://www.adventrx.com
SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX) today announced that it will host a conference call with
simultaneous webcast to discuss first quarter 2008 results on Monday, May
12th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine, Chief
Executive Officer and President, and Mark N. K. Bagnall, Chief Financial
Officer and Executive Vice President, will host the conference call.
The conference call may be accessed by dialing (888) 215-7013 for
domestic callers and (913) 312-1235 for international callers. The webcast
will be available live via the Internet by accessing ADVENTRX's web site at
http://www.adventrx.com under "Investors". Replays of the webcast will be
available for 30 days on ADVENTRX's web site, and a phone replay will be
available through May 17, 2008 by dialing (888) 203-1112 and entering the
passcode 5439297.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-
licensing, developing and commercializing proprietary product candidates
primarily for the treatment of cancer and infectious disease. The Company
seeks to improve the performance and commercial potential of existing
treatments by addressing problems associated with these treatment regimens.
More information can be found on ADVENTRX's web site at http://www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
 back to top
Related links:
http://www.adventrx.com/
CONTACT:
Ioana C. Hone of ADVENTRX Pharmaceuticals,
Inc., +1-858-552-0866
|
